Search results
Results from the WOW.Com Content Network
The following table provides the reduction potentials of the indicated reducing agent at 25 °C. For example, among sodium (Na), chromium (Cr), cuprous (Cu +) and chloride (Cl −), it is Na that is the strongest reducing agent while Cl − is the weakest; said differently, Na + is the weakest oxidizing agent in this list while Cl is the strongest.
Pages in category "Reducing agents" The following 102 pages are in this category, out of 102 total. This list may not reflect recent changes. ...
This is a list of 5α-reductase inhibitors (5α-RIs), drugs which inhibit one or more isoforms of the enzyme 5α-reductase.This enzyme is responsible for the conversion of the androgen hormone testosterone into the more potent dihydrotestosterone (DHT) and is essential for the production of neurosteroids like allopregnanolone, tetrahydrodeoxycorticosterone (THDOC), and 3α-androstanediol from ...
The list of medications with antipyretic effects includes many common drugs that also have analgesic and anti-inflammatory activity, several of which are commonly sold over-the-counter (OTC). NSAIDs (non-steroidal anti-inflammatory drugs), a broad class of medications that in addition to their defining effect of reducing inflammation, also tend ...
a strong base; deprotonates ketones and esters to generate enolate derivative Sodium borohydride: a versatile reducing agent; converts ketones and aldehydes to alcohols Sodium chlorite: in organic synthesis, used for the oxidation of aldehydes to carboxylic acids Sodium hydride: a strong base used in organic synthesis Sodium hydroxide
This is a complete list of clinically approved prescription antidepressants throughout the world, as well as clinically approved prescription drugs used to augment antidepressants or mood stabilizers, by pharmacological and/or structural classification. Chemical/generic names are listed first, with brand names in parentheses.
This is a list of chemotherapeutic agents, also known as cytotoxic agents or cytostatic drugs, that are known to be of use in chemotherapy for cancer.This list is organized by type of agent, although the subsections are not necessarily definitive and are subject to revision.
Bimagrumab, an experimental drug, works by inhibiting the action of myostatin, which limits the size of skeletal muscle. The drug has shown the ability to increase lean mass simultaneously to decreasing fat mass in obese humans, which is beneficial because it preserves or increases energy expenditure while reducing risks associated with excess fat.